- Open Access
T1 inversion recovery pulse sequence: could it replace T1 spin echo sequence in neuroimaging by improving tissue contrast?
Egyptian Journal of Radiology and Nuclear Medicine volume 50, Article number: 26 (2019)
T1 inversion recovery (T1IR) sequence improved tissue contrast by providing higher gray matter-white matter contrast ratio (GM-WM contrast ratio) and higher lesion contrast noise ratio (CNR). This study aims to highlight its significance in the evaluation of space-occupying lesions whether intra-axial or extra-axial and also in multiple sclerosis (MS) by comparing it with T1 spin echo (T1SE) sequence.
In a total of 50 patients, 14 patients with extra-axial lesions, 18 patients with intra-axial lesions, and 18 patients with multiple sclerosis were included. The CNR was significantly higher for pre-contrast T1IR images than for pre-contrast T1SE (− 13.04 (1.20) vs − 7.73 (0.70); p value < 0.01). After giving intravenous contrast media, CNR in T1SE was higher than T1IR (11.14 (1.75) vs 9.41 (1.83)) without statistical significance (p value = 0.19) and CNR was higher in T1IR than T1SE in lesions with low enhancement ratio (ER). As well, the overall number of lesions was higher on T1IR especially in MS (10.67 (2.26) vs 3.89 (1.05); p value < 0.01).
On pre-contrast sequences, T1IR could be used as an added sequence in most brain lesions giving higher lesion CNR. After giving intravenous contrast media, T1IR could be used in lesions with low ER. It also could be used in situations in which gadolinium injection is contraindicated and also could be used in follow-up of MS patient by detecting a higher number of lesions that can be easily missed in T1SE.
Inversion recovery sequences are commonly used as FLAIR (fluid attenuated inversion recovery) and STIR (short tau inversion recovery) by suppressing MR signals from CSF and fat, respectively. However, it could also be used to generate T1-weighted images that are called T1 inversion recovery (T1IR) .
Through reducing the acquisition time in this sequence and increasing its spatial resolution by applying multishot echo planar imaging and fast spin echo imaging, it became practical to be used in neuroimaging . Furthermore, it improved tissue contrast by providing higher gray matter-white matter (GM-WM) contrast ratio and higher lesion contrast noise ratio (CNR), so it could be used in the evaluation of neoplastic space-occupying lesion whether extra-axial or intra-axial .
It also could be used in the diagnosis, monitoring disease progression, and treatment efficacy in multiple sclerosis (MS) as it detects the black hole lesions that show better correlation with clinical disability . Conversely, the correlation between the current magnetic resonance (MR) measures and clinical disability measures is still weak (that is called MRI/clinical dissociation), making the current MRI sequences inadequate in the monitoring of disease activity and insufficient in the assessment of treatment efficacy [5,6,7]. T1IR, by providing higher GM-WM contrast ratio and lesion CNR, might aid in revealing a higher number of cortical lesions in MS that go undetected in conventional MR techniques, making it more promising for accurate quantification of lesion load and disease burden [8,9,10].
The goal of this study is to highlight the significance of T1IR sequence in neuroimaging in the evaluation of neoplastic space-occupying lesions whether intra-axial or extra-axial and also in the evaluation of demyelinating diseases such as multiple sclerosis, by comparing it to the conventional T1 spin echo (T1SE) to determine which of them would be the most valuable sequence.
Methods and materials
This study was carried at Menoufia University Hospitals, and all study procedures were approved by the ethical committee of Menoufia Faculty of Medicine and after taking written informed consent from patients involved in the study; it was prospectively performed from August 2017 to July 2018. Fifty patients were recruited and subjected to MRI imaging. We included neoplastic space-occupying lesions whether primary or metastatic. Other non-neoplastic space-occupying lesions were excluded (infective or inflammatory). We also included demyelinating lesions due to multiple sclerosis and excluded demyelinating lesions due to viral, metabolic, toxic, and vascular causes. All MR examinations were performed using a 1.5-T MR scanner (Toshiba Excelart Vantage, Japan) and standard 16-channel headcoil. We obtained T1SE pre-contrast and post-contrast (axial), T1IR pre-contrast and post-contrast (axial), T2WI (axial), FLAIR (axial), T2WI (coronal), T1WI (sagittal), and diffusion-weighted (axial) images. Post-contrast images were performed 4 min after the injection of a gadolinium contrast agent (gadopentetic acid, Gd DTPA, 0.1 mmol/kg, Magnevist, Bayer Health Care, German) by manual injection followed by 20 ml saline flush. Scan parameters for T1SE (axial) were as follows: repetition time (TR)/echotime (TE) 465 ms/12 ms, bandwidth 140 kHz, slice thickness 5 mm, matrix 208 × 352, flip angle 90, number of excitations (NEX) 1, field of vision (FOV) 24 cm, number of slices 20, and scan time 2 min 45 s. Scan parameters for T1IR (axial) were as follows: repetition time (TR)/echotime (TE) 3550 ms/18 ms, bandwidth 98 kHz , slice thickness 5 mm, matrix 192 × 336, flip angle 90:180, number of excitations (NEX)1, field of vision (FOV) 24 cm, number of slices 20, and scan time 2 min 58 s.
In our study, images were interpreted by two radiologists—blinded to clinical data—with experience over 10 years, in conjoint reading sessions, and then, the final decision was taken by discussion and consensus. These images were analyzed in both T1SE (axial) and T1IR (axial) sequences with respect to lesion number and signal intensity (SI). The SI was calculated digitally by drawing a circular region of interest (ROI) on the lesion, approximately 100 mm3. The images of interest were displayed side by side on the workstation (Aze Virtual Place FujinRaijin 310).
First, we compared the degree of lesion contrast noise ratio (CNR) between T1SE and T1IR before and after giving intravenous contrast media. CNR was defined as the difference between the lesion signal intensity and white matter signal intensity (SI) divided by the lesion signal intensity standard deviation (SD). We further compared the degree of CNR between T1SE and T1IR sequences according to each type of lesion into three subgroups (extra-axial, intra-axial, MS).
After giving intravenous contrast media, we compared the CNR between T1SE and T1IR sequences according to enhancement ratio (ER) into two subgroups (low enhancement ratio and high enhancement ratio): ER = post-contrast (lesion contrast ratio)/pre-contrast (lesion contrast ratio). Lesion contrast ratio was defined as SI of lesion divided by SI of white matter. The median overall value of all lesion ER was (0.68), so we divided lesions into high enhancement ratio and low enhancement ratio groups based on this value. Finally, we assessed the difference between T1SE and T1IR sequences after giving intravenous contrast media according to number of enhanced lesions (Fig. 1). All statistical analysis was performed on Microsoft Excel 2016 using a one-tailed paired t test. A p value of less than 0.05 was considered statistically significant.
During the study period, a total of 50 patients were included (21 males and 29 females). The mean age was 43 years old (age range 19–73 years). Extra-axial lesions were identified in 14 patients (5 with meningioma, 3 with metastasis of unknown origin, 2 with vestibular shwannoma, 2 with metastasis from breast carcinoma, 1 with metastasis from rhabdomyosarcoma, and 1 with secondary lymphoma); meanwhile, intra-axial lesions were identified in 18 patients (5 with metastasis from bronchogenic carcinoma, 5 with glioblastoma, 4 with anaplastic astrocytoma, 2 with metastasis from breast carcinoma, and 2 with metastasis from unknown origin) and MS lesions were also identified in 18 patients. The SI for both the lesion and white matter was recorded then CNR was calculated for both pre-contrast and post-contrast study.
Comparing T1SE and T1IR based on CNR
The CNR was significantly higher in pre-contrast T1IR than in pre-contrast T1SE with mean value − 13.04 (1.20) vs − 7.73 (0.70) and with p value < 0.01 (Fig. 2). Furthermore, the CNR was higher in post-contrast T1SE than in post-contrast T1IR, although difference did not achieve statistical significance with mean value 11.14 (1.75) vs 9.41 (1.83) and p value = 0.19 as shown in Table 1.
Comparing T1SE and T1IR based on type of lesion
The CNR was significantly higher in T1IR before contrast injection at all types of lesions either extra-axial, intra-axial, or MS with mean values − 13.90 (2.86), − 12.87 (2.40), and − 12.69 (1.63) and with p values 0.02, < 0.05, and 0.01, respectively (Figs. 2, 3, and 4). On the other side, post-contrast T1SE achieved higher efficacy without statistical significance for extra-axial lesions with mean value 18.48 (3.48) vs 13.17 (3.01) and with p value 0.06. For intra-axial lesions, post-contrast T1SE lesion CNR was, as well, higher without statistical significance with mean value 17. 08 (2.65) vs 16.46 (4.07) and with p value 0.45. For MS, 17 from 18 patients did not have active lesions, so their SI did not change on post-contrast study. Therefore, we did not assess the post-contrast values in them (Table 2).
Comparing T1SE and T1IR based on ER
The mean CNR value was significantly higher in T1IR in the weak enhancement ratio group with mean value 18.91 (2.68) vs 1.05 (0.59). Meanwhile, it was significantly higher in T1SE in the high enhancement group (21.24 (1.92) vs 0.64 (0.37)) and the results were statistically significant in both groups (p value < 0.01) as shown in (Table 3).
Comparing T1SE and T1-IR based on number of lesions
The overall number of lesions was significantly higher in T1IR than in T1SE with mean value 4.94 (0.92) vs 2.36 (0.37) and p value < 0.01 (Table 1). Regarding subgroup analysis, we found that T1IR was statistically significant in MS group as regards to the number of lesions (10.67 (2.26) vs 3.89 (1.05); p value < 0.01; Fig. 4), but it showed no difference in extra- or intra-axial lesions with mean values 1.29 (0.16) vs 1.29 (0.16) (p value = 0.5) and 2.19 (0.94) vs 1.75 (0.57) (p value 0.13; Table 4).
Conventional MR sequences produce only positive longitudinal magnetization. Conversely, inversion recovery (IR) sequences are displayed after rotating the positive longitudinal magnetization into negative magnetization, so IR sequences can generate more tissue contrast . T1IR is an MRI sequence with 180 radio-frequent pulses with high lesion CNR and GM-WM contrast ratio than T1SE sequence, so it can be used in the evaluation of various neoplastic space-occupying lesions and demyelinating diseases such as multiple sclerosis . In our study, we compared between T1IR and T1SE on 50 patients with different brain diseases aiming to reveal superiority of each sequence in each brain disease. In our study, on non-contrast sequences, T1IR was better than T1SE, giving higher CNR with mean value − 13.04 (1.20) for all types of lesions (multiple sclerosis, intra-axial, and extra-axial space-occupying lesions).
The same of our results were reported by Bing et al.  in a study carried on 30 patients with various neurologic diseases, and T1IR was superior to T1SE with improved determination of lesion extent, conspicuity, and lesion delineation; this was because T1SE had the poorest GM-WM contrast and poor lesion-to-background contrast by visual comparison between T1SE and T1IR. As well, Rydberg et al. , in a study carried on 15 patients with contrast-enhancing brain space-occupying lesions, showed that T1IR had quantitatively comparable or superior lesion-to-background contrast ratio, GM-WM contrast ratio, and superior CSF-WM contrast ratio; also, it provided qualitatively superior lesion detection compared to T1SE, as well as, superior lesion conspicuity and image contrast. In the same context, Lee et al. , in a study carried on 15 patients with 18 lesions, showed that T1IR was superior to T1SE in the determination of lesion extent in 16 lesions and provided higher CNR and GM-WM contrast ratio, but it takes more time than T1SE. However, Qian et al.  reported opposite results to our study, as T1SE was sensitive than T1IR in the detection of brain metastasis, but this can be accounted by the difference of nature of the disease, because many of metastatic lesions included in this study were small hemorrhagic lesions that were better detected on T1SE because of its sensitivity to hemorrhagic lesions.
We also reported in our study that after giving intravenous contrast media, T1IR was better than T1SE, giving higher CNR in lesions with low enhancement ratio with mean value 18.91 (2.68) vs 1.05 (0.59). On the other side, T1SE was better than T1SE in lesions with high enhancement ratio with mean value 21.24 (1.92) vs 0.64 (0.37). This goes on with results of Bandai et al. , in which T1IR provided higher tumor-to-WM contrast ratio with mean value 38.89 (2.68) in 13 enhanced tumors, and it also revealed 7 non-enhanced and low enhanced tumors that were poorly visualized on T1SE. The same results were reported in other studies [14, 15].
In our study, T1IR aided in the detection of higher number of lesions than T1SE especially in patients with multiple sclerosis with mean value 10.67 (2.26) vs 3.89 (1.05). This seemed consistent with Harel et al. , Sethi et al. , and Nelson et al  who showed that T1IR improved the detection of cortical and juxtacortical lesions in progressive multiple sclerosis with accurate localization of them; this can be due to the higher WM-GM contrast ratio, making it extremely useful in follow-up of these patients.
We encountered some limitations in our study. Firstly, our study included only 50 patients; this number reveals minor differences between T1IR and T1SE especially with different brain lesions. Secondly, most of our MS patients were in inactive state. Therefore, we could not assess their SI on post-contrast lesions. Finally, we did not assess the size of lesions in both sequences. Hence, more studies should be done to reveal the full comparison between both sequences.
On pre-contrast sequences, T1IR could be used as an added sequence in most brain lesions giving higher lesion CNR. After giving intravenous contrast media, T1IR could be used in lesions with low ER. It also could be used in situations in which gadolinium injection is contraindicated and also could be used in the follow-up of MS patients by detecting a higher number of lesions that can be easily missed in T1SE.
Contrast noise ratio
Fluid-attenuated inversion recovery
Gray matter-white matter
Short tau inversion recovery
T1 inversion recovery
T1 spin echo
Hou P, Hasan KM, Sitton CW, Wolinsky JS, Narayana PA (2005) Phase-sensitive T1 inversion recovery imaging: a time-efficient interleaved technique for improved tissue contrast in neuroimaging. Am J Neuroradiol 26(6):1432–1438
Sheppard S, Davis PC, Kater G, Peterson JE (1998) Inversion-recovery echo-planar MR in adult brain neoplasia. Am J Neuroradiol 19(2):267–273
Qian YF, Yu CL, Zhang C, Yu YQ (2008) MR T1-weighted inversion recovery imaging in detecting brain metastases: could it replace T1-weighted spin-echo imaging? Am J Neuroradiol 29(4):701–704
Yousry TA, Filippi M, Becker C, Horsfield MA, Voltz R (1997) Comparison of MR pulse sequences in the detection of multiple sclerosis lesions. Am J Neuroradiol 18(5):959–963
Datta S, Sajja BR, He R, Wolinsky JS, Gupta RK, Narayana PA (2006) Segmentation and quantification of black holes in multiple sclerosis. Neuroimage 29(2):467–474
Healy BC, Buckle GJ, Ali EN, Egorova S, Khalid F, Tauhid S, Bakshi R (2017) Characterizing clinical and MRI dissociation in patients with multiple sclerosis. J Neuroimaging 27(5):481–485
Klawiter EC (2013) Current and new directions in MRI in multiple sclerosis. Continuum 19(4 Multiple Sclerosis):1058
Farshidfar Z, Faeghi F, Haghighatkhah HR, Abdolmohammadi J (2017) The optimization of magnetic resonance imaging pulse sequences in order to better detection of multiple sclerosis plaques. J Biomed Phys Eng 7(3):265
Simon B, Schmidt S, Lukas C, Gieseke J, Träber F, Knol DL, Wattjes MP (2010) Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla. Eur Radiol 20(7):1675–1683
Filippi M, Baratti C, Yousry T, Horsfield MA, Mammi S, Becker C, Comi G (1996) Quantitative assessment of MRI lesion load in multiple sclerosis: a comparison of conventional spin-echo with fast fluidattenuated inversion recovery. Brain 119(4):1349–1355
Rydberg JN, Hammond CA, Iii JH, Jack CR Jr, Grimm RC, Riederer SJ (1996) T1-weighted MR imaging of the brain using a fast inversion recovery pulse sequence. J Magn Reson Imaging 6(2):356–362
Lee JK, Choi HY, Lee SW, Baek SY, Kim HY (2000) Usefulness of T1-weighted image with fast inversion recovery technique in intracranial lesions: comparison with T1-weighted spin echo image. Clin Imaging 24(5):263–269
Bandai H, Tsunoda A, Mitsuoka H, Arai H, Sato K, Makita J (2002) Fast inversion recovery magnetic resonance imaging with the real reconstruction method: a diagnostic tool for cerebral gliomas. Neurol Med Chir 42(1):5–10
Fischbach F, Bruhn H, Pech M, Neumann F, Ricke J, Felix R, Hoffmann KT (2005) Efficacy of contrast medium use for neuroimaging at 3.0 T: utility of IR-FSE compared to other T1-weighted pulse sequences. J Comput Assist Tomogr 29(4):499–505
Batouli A, Kanal E, Gholamrezanezhad A, Spearman M (2018) T1-weighted parenchyma attenuated inversion recovery: a novel sequence that improves contrast ratio of enhancing brain lesions. Diagn Interv Imaging 99(1):29–35
Harel A, Ceccarelli A, Farrell C, Fabian M, Howard J, Riley C, Inglese M (2016) Phase-sensitive inversion-recovery MRI improves longitudinal cortical lesion detection in progressive MS. PloS one 11(3):e0152180
Sethi V, Yousry TA, Muhlert N, Ron M, Golay X, Wheeler-Kingshott C, Chard DT (2012) Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI. J Neurol Neurosurg Psychiatry jnnp-2012.
Nelson F, Poonawalla AH, Hou P, Huang F, Wolinsky JS, Narayana PA (2007) Improved identification of intracortical lesions in multiple sclerosis with phase-sensitive inversion recovery in combination with fast double inversion recovery MR imaging. Am J Neuroradiol 28(9):1645–1649
There is no acknowledgement.
Availability for data and materials
The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.
This study had no funding from any resource.
Ethics approval and consent to participate
All study procedures were conducted in accordance with the Declaration of Helsinki and were approved by the ethical committee of Menoufia Faculty of Medicine, and all data were extracted after taking written informed consent from patients involved in the study.
Consent for publication
All patients included in this research gave written informed consent to publish the data contained within this study.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Shawky, M., Habib, R. & Elsawaf, A. T1 inversion recovery pulse sequence: could it replace T1 spin echo sequence in neuroimaging by improving tissue contrast?. Egypt J Radiol Nucl Med 50, 26 (2019). https://doi.org/10.1186/s43055-019-0028-5
- T1 inversion recovery
- T1 spine echo
- Tissue contrast